AltPep Corporation

About AltPep Corporation

AltPep is a biotechnology company focused on transforming the diagnosis and treatment of amyloid diseases, such as Alzheimer's and Parkinson's, by targeting early molecular triggers to change the course of these diseases before symptoms appear. Their mission is to enable early action and develop disease-modifying treatments and detection tools for over a billion people affected globally.

Products & Services

SOBIN Therapeutics:In development to target and neutralize toxic soluble oligomers associated with amyloid diseases, used in concert with early detection.

SOBA Diagnostics:Highly sensitive, simple blood tests in development to aid in the early detection of amyloid diseases.

Therapeutics and Diagnostics Platform:A platform based on custom-designed synthetic peptides to detect and neutralize α-sheet toxic soluble oligomers for early treatment and diagnosis of amyloid diseases, starting with Alzheimer's and Parkinson's.

Specialties

Amyloid disease treatment Early detection of amyloid diseases α-sheet targeting platform Custom-designed synthetic peptides Alzheimer's and Parkinson's disease research

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series B T: - FT: Series B	A: 52900000 MR: - FA: $52.9 million FAN: 52900000	D: 2023-06-22 FD: 2023-06-22	6 investors

Series B Latest

2023-06-22

$52.9M

6 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

H

Hector Aldaz

Principal Scientist

V

Vince Aoki

CLIA Lab Director

K

Kurt Becker

Chief Legal Officer

J

Jeri Beltman

Acting Director, Regulatory Affairs

G

Gil Block

Chief Medical Officer

L

Lizzy Canarie

Scientist

View 45 more team members with Pro

Unlock Full Team Directory

Recent News